Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression

Dialogues in Clinical Neuroscience

Volumn 13, Issue 1, 2011, Pages 139-145

  Baeken, Chris ^a   De Raedt, Rudi ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Depression; Neurobiological mechanism; Neurocircuitry; rTMS; Treatment; Unipolar

Indexed keywords

NEUROTRANSMITTER; NEUROTROPHIC FACTOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; MOOD; NERVE CELL; NEUROBIOLOGY; NEUROENDOCRINOLOGY; NEUROIMAGING; PREFRONTAL CORTEX; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN; BRAIN MAPPING; DEPRESSION; METHODOLOGY; NERVE CELL NETWORK; NERVE TRACT; PATHOLOGY; PHYSIOLOGY;

BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER; HUMANS; NERVE NET; NEURAL PATHWAYS; NEUROBIOLOGY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79955789061     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358:55-68.
2. Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res. 2007;41:189-206.
3. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53:649-659.
4. Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2:343-351.
5. George MS, Nahas Z, Li X, et al. Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). Semin Clin Neuropsychiatry. 2002;7:293-304.
6. Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-173.
7. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216.
8. Brakemeier EL, Luborzewski A, Danker-Hopfe H, Kathmann N, Bajbouj M. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 2007;41:606-615.
9. Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480-491.
10. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65-75.
11. Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010;40:1789-1795.
12. Epstein CM. TMS stimulation coils. In: Wasserman EM, Epstein CM, Ziemann U, Walsh V, Paus T, Lisanby SH, eds. The Oxford Handbook of Transcranial Stimulation. Oxford, UK; New York, NY: Oxford University Press; 2008:25-32.
13. Fitzgerald PB, Oxley TJ, Laird AR, Kulkarni J, Egan GF, Daskalakis ZJ. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006;148:33-45.
14. Garcia-Toro M, Montes JM, Talavera JA. Functional cerebral asymmetry in affective disorders: new facts contributed by transcranial magnetic stimulation. J Affect Disord. 2001;66:103-109.
15. Padberg F, George MS. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol. 2009;219:2-13.
16. Buck R. The biological affects: a typology. Psychol Rev. 1999;106:301-336.
17. Paus T, Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J Psychiatry Neurosci. 2004;29:268-279.
18. Davidson RJ, Lewis DA, Alloy LB, et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry. 2002;52:478-502.
19. Chen R, Gerloff C, Classen J, Wassermann EM, Hallett M, Cohen LG. Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters. Electroencephalogr Clin Neurophysiol. 1997;105:415-421.
20. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability. Exp Brain Res. 2000; 133:425-430
21. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133-1141.
22. Knoch D, Treyer V, Regard M, Muri RM, Buck A, Weber B. Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. Neuroimage. 2006;3:641-648.
23. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003;65:193-207.
24. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure Function. 2008;213:93-118.
25. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology. 2011;36:183-206.
26. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477-501.
27. Erickson K, Drevets W, Schulkin J. Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci Biobehav. 2003;27:233-246.
28. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7:254-275.
29. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603-1613.
30. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133-1141.
31. Speer AM, Benson BE, Kimbrell TK, et al. Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. J Affect Disord. 2009;115:386-394.
32. Baeken C, De Raedt R, Van Hove C, Clerinx P, De Mey J, Bossuyt A. HFrTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr. 2009;14:439-448.
33. Herwig U, Lampe Y, Juengling FD, et al. Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res. 2003;37:267-275.
34. Paillère Martinot ML, Galinowski A, Ringuenet D, et al. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacol. 2010;13:45-59.
35. Li CT, Wang SJ, Hirvonen J, et al. Antidepressant mechanism of addon repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord. 2010;127:219-229.
36. Wu J, Buchsbaum MS, Gillin JC, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry. 1999;156:1149-1158.
37. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry. 2001;158:405-415.
38. Langguth B, Wiegand R, Kharraz A, et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuroendocrinology Letters. 2007;28:633-638.
39. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci. 2001;14:1405-1411.
40. Kito S, Fujita K, Koga Y. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology. 2008;58:29-36.
41. Kito S. Fujita K, Koga Y. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2008;20:74-80.
42. Shajahan PM, Glabus MF, Steele JD, et al. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:945-954.
43. Nahas Z, Teneback CC, Kozel A, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001;13:459-470.
44. Luborzewski A, Schubert F, Seifert F, et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res. 2007;41:606-615.
45. Loo CK, Sachdev PS, Haindl W, et al. High (15 Hz) and low (1 Hz) frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients. Psych Med. 2003;33:997-1006.
46. Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res. 2001;35:193-215.
47. Schutter DJ, van Honk J. An endocrine perspective on the role of steroid hormones in the antidepressant treatment efficacy of transcranial magnetic stimulation. Psychoneuroendocrinology. 2010;35:171-178.
48. Keck ME. rTMS as treatment strategy in psychiatric disorders--neurobiological concepts. Suppl Clin Neurophysiol. 2003;56:100-116.
49. Baeken C, De Raedt R, Leyman L, et al. The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients. J Affect Disord. 2009;113:100-108.
50. Pridmore S. Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiatry Clin Neurosci. 1999;53:33-37.
51. Szuba MP, O'Reardon JP, Rai AS, et al. Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biol Psychiatry. 2001;50:22-27.
52. Keck ME, Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides. 2001;22:835-844.
53. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci. 2004;29:185-193.
54. Hoeppner J, Padberg F, Domes G, et al. Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression. Eur Arch Psychiatry Clin Neurosci. 2010;260:197-202.
55. Baeken C, De Raedt R, Santermans L, et al. HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:684-687.
56. Pogarell O, Koch W, Pöpperl G, et al. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res. 2006;40:307-314.
57. Pogarell O, Koch W, Pöpperl G, et al. Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine. Psychiatry Res. 2007;156:251-55.
58. Kuroda Y, Motohashi N, Ito H, Ito S, Takano A, Nishikawa T, Suhara T. Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression. J Affect Disord. 2006;95:35-42.
59. Kuroda Y, Motohashi N, Ito H, et al. Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: preliminary L-[β-11C]DOPA positron emission tomography study in patients with depression. Psychiatry Clin Neurosci. 2010;64:659-662.
60. Neumeister A, Charney DS. Monoaminergic transmitter systems. In: D'haenen, HAH, den Boer, JA and Willner, P, eds. Biological Psychiatry. Chichester, UK: John Wiley & Sons Ltd; 2002:727-738.
61. Baeken C, De Raedt R, Bossuyt A, et al. The impact of HF-rTMS treatment on serotonin 2A receptors in unipolar melancholic depression. Brain Stimulation. In press.
62. Burnet PW, Sharp T, LeCorre SM, Harrison PJ. Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci Lett .1999;277:79-82.
63. Zanardi R, Artigas F, Moresco R, et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol. 2001;21:53-58.
64. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33:73-83.
65. Vaidya VA, Terwilliger RM, Duman RS. Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett. 1999;262:1-4.
66. O'Reardon JP, Cristancho P, Pilania P, Bapatla KB, Chuai S, Peshek AD. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety. 2007;24:537-544.
67. Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004;29:252-265.
68. Levkovitz Y, Grisaru N, Segal M. Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus Neuropsychopharmacology. 2001;24, 608-616.
69. Michael N, Gösling M, Reutemann M, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci. 2003;17:2462-2468.
70. Daskalakis ZJ, Möller B, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006;174:403-412.
71. Brunoni AR, Boggio PS, Fregni F. Can the 'yin and yang' BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry? Med Hypotheses. 2008;71:279-282.
72. Müller MB, Toschi N, Kresse AE, Post A, Keck ME. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 2000:23:205-215.
73. Zanardini R, Gazzoli A, Ventriglia M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006;91:83-86.
74. Yukimasa T, Yoshimura R, Tamagawa A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006;39:52-59.
75. Sullivan RM, Gratton A. Prefrontal cortical regulation of hypothalamicpituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology. 2002;27:99-114.
76. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(suppl 1):2-19.
77. Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract. 2007;61:2030-2040.